Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 1098Session 89R

Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

House Committee Report

Underlined text would be added to current law. Struck-through text would be removed.

 
 
  By: Blanco, et al. S.B. No. 1098
 
  (Hull)
 
   
 
  A BILL TO BE ENTITLED
  AN ACT
  relating to the disclosure by a pharmacy to a patient of certain
  price information for a drug or biological product.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 562.003, Occupations Code, is amended to
  read as follows:
         Sec. 562.003.  DISCLOSURE OF PRICE; PATIENT'S OPTION.  (a)  A
  pharmacy shall disclose the lowest cost cash price at that pharmacy
  for the drug or biological product prescribed to the patient.
         (b)  If the price of a drug or biological product to a patient
  is lower than the amount of the patient's copayment under the
  patient's prescription drug insurance plan, the pharmacist shall
  offer the patient the option of paying for the drug or biological
  product at the lower price instead of paying the amount of the
  copayment.
         SECTION 2.  This Act takes effect September 1, 2025.

Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.